| LM ID |
Analyte |
Treatment |
Time(hrs) |
Sample ID |
Value |
Units |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
0.0 |
BCD100624C002 |
17.1 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
0.5 |
BCD100624C005 |
15.1 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
1.0 |
BCD100624C009 |
17.5 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
2.0 |
BCD100624C013 |
14.4 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
4.0 |
BCD100624C017 |
21.5 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
8.0 |
BCD100624C021 |
21.3 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
12.0 |
BCD100624C025 |
21.8 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
Lipid-depleted/compactin |
24.0 |
BCD100624C029 |
14.4 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
0.0 |
BCD100624C001 |
12.4 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
0.5 |
BCD100624C003 |
12.9 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
1.0 |
BCD100624C007 |
16.6 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
2.0 |
BCD100624C011 |
19 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
4.0 |
BCD100624C015 |
13.7 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
8.0 |
BCD100624C019 |
18 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
12.0 |
BCD100624C023 |
19.8 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
C |
24.0 |
BCD100624C027 |
17.4 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
0.5 |
BCD100624C006 |
16.9 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
1.0 |
BCD100624C010 |
14.8 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
2.0 |
BCD100624C014 |
19.4 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
4.0 |
BCD100624C018 |
13.6 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
8.0 |
BCD100624C022 |
19.4 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
12.0 |
BCD100624C026 |
21.1 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol + Lipid-depleted/compactin |
24.0 |
BCD100624C030 |
15.1 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
0.5 |
BCD100624C004 |
19.2 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
1.0 |
BCD100624C008 |
23.2 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
2.0 |
BCD100624C012 |
15.6 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
4.0 |
BCD100624C016 |
13.6 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
8.0 |
BCD100624C020 |
23.1 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
12.0 |
BCD100624C024 |
19 |
pmol/sample |
| LMFA01030159 |
11,14,17-eicosatrienoic acid |
25OH-Chol |
24.0 |
BCD100624C028 |
20.8 |
pmol/sample |